Clinical validation of clinical decision support systems for medication review: A scoping review

Br J Clin Pharmacol. 2022 May;88(5):2035-2051. doi: 10.1111/bcp.15160. Epub 2021 Dec 15.

Abstract

The aim of this scoping review is to summarize approaches and outcomes of clinical validation studies of clinical decision support systems (CDSSs) to support (part of) a medication review. A literature search was conducted in Embase and Medline. In total, 30 articles validating a CDSS were ultimately included. Most of the studies focused on detection of adverse drug events, potentially inappropriate medications and drug-related problems. We categorized the included articles in three groups: studies subjectively reviewing the clinical relevance of CDSS's output (21/30 studies) resulting in a positive predictive value (PPV) for clinical relevance of 4-80%; studies determining the relationship between alerts and actual events (10/30 studies) resulting in a PPV for actual events of 5-80%; and studies comparing output of CDSSs to chart/medication reviews in the whole study population (10/30 studies) resulting in a sensitivity of 28-85% and specificity of 42-75%. We found heterogeneity in the methods used and in the outcome measures. The validation studies did not report the use of a published CDSS validation strategy. To improve the effectiveness and uptake of CDSSs supporting a medication review, future research would benefit from a more systematic and comprehensive validation strategy.

Keywords: adverse drug events; clinical decision support systems; inappropriate prescriptions; validation studies.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Decision Support Systems, Clinical*
  • Drug-Related Side Effects and Adverse Reactions* / prevention & control
  • Humans
  • Medication Review
  • Outcome Assessment, Health Care
  • Potentially Inappropriate Medication List